---
title: "Regulatory roadmap: Medicinal product, Switzerland"
url: https://normiq.app/en/roadmap/switzerland/medicinal-product
language: en
updated: 2026-11-17
---

# Regulatory roadmap: Medicinal product, Switzerland

11 phases · 40 steps

This is the order in which Normiq organises market access for the market "Switzerland" and the category "Medicinal product". Each step has a detailed guide — how to proceed, best practices, common mistakes, reference articles — reserved for Normiq accounts.

1. Phase 1

   ## Integrity and transparency (Switzerland)

   Swiss obligations governing advantages granted to healthcare professionals and the transparency of discounts. Concerns sales and marketing as much as regulatory affairs.

   1. ### Switzerland — determine whether transparency applies to you

      required · 10 d

      Establish whether your products and commercial practices fall within Art. 55 and 56 of the Therapeutic Products Act.

   2. ### Switzerland — account for discounts and rebates

      required · 20 d

      Discounts and rebates must appear in supporting documents, accounts and books, and be disclosed to the Federal Office of Public Health on request.

   3. ### Switzerland — set up internal control arrangements

      required · 30 d

      A designated person, ten years of retention for agreements, and a list of those who received lawful advantages.

   4. ### Switzerland — congresses, training and paid services

      required · 20 d

      Hard thresholds: an own contribution of one third or one fifth, meals capped at CHF 100, advantages of modest value capped at CHF 300 a year.

2. Phase 2

   ## Preclinical Development

   Toxicology, pharmacology, and pharmacokinetic studies

   1. ### Synthesis and characterization of the active substance

      required · 60 d

      Development of the active pharmaceutical ingredient (API)

   2. ### Studies toxicologiques

      required · 90 d

      Acute, subacute, chronic toxicity, genotoxicity, carcinogenicity

   3. ### Studies pharmacologiques

      required · 30 d

      Pharmacodynamics, pharmacokinetics, ADME

3. Phase 3

   ## Authorisation Application d'clinical trial

   IND (EU) ou application d'authorisation Swissmedic

   1. ### Protocol clinical trial Phase I

      required · 20 d

      Define objectives, inclusion/exclusion criteria, endpoints

   2. ### Investigator's Brochure (IB)

      required · 15 d

      Compile all available preclinical and clinical data

   3. ### Soumettre la application CTA

      required · 25 d

      Submission to the competent authority and ethics committee

4. Phase 4

   ## Clinical Trials Phase I

   First-in-human administration - Safety and tolerability

   1. ### Recruitment Phase I
      required · 30 d

   2. ### Conduct de l'essai Phase I

      required · 120 d

      Dose escalation, close monitoring

   3. ### Phase I Results Analysis
      required · 30 d

5. Phase 5

   ## Clinical Trials Phase II

   Preliminary efficacy and dose determination

   1. ### Protocol Phase II
      required · 30 d
   2. ### Application authorisation Phase II
      required · 20 d
   3. ### Recruitment Phase II
      required · 90 d
   4. ### Conduct essai Phase II
      required · 180 d
   5. ### Analysis Phase II
      required · 45 d

6. Phase 6

   ## Clinical Trials Phase III

   Confirmed efficacy and safety - Pivotal trials

   1. ### Protocols Phase III

      required · 60 d

      Generally 2 independent pivotal trials

   2. ### Authorisation Phase III
      required · 30 d

   3. ### Recruitment Phase III
      required · 180 d

   4. ### Conduct essais Phase III
      required · 365 d

   5. ### Analysis statistique Phase III
      required · 95 d

7. Phase 7

   ## Pharmaceutical Development et production

   Dosage form development and scale-up

   1. ### Formulation development

      required · 120 d

      Dosage form, excipients, stability

   2. ### Studies de stabilité

      required · 180 d

      Accelerated and long-term stability per ICH Q1A

   3. ### Manufacturing process validation

      required · 65 d

      Scale-up validation, quality controls

8. Phase 8

   ## GMP Certification

   Bonnes Pratiques de Fabrication - Mandatory

   1. ### GMP Compliance

      required · 60 d

      Infrastructure, equipment, GMP procedures

   2. ### GMP Inspection

      required · 60 d

      Inspection by the competent authority

9. Phase 9

   ## CTD Dossier Compilation

   Common Technical Document - Standardized ICH format

   1. ### Module 1 - Administrative Data
      required · 10 d

   2. ### Module 2 - Summaries

      required · 20 d

      Quality, non-clinical, and clinical summaries

   3. ### Module 3 - Quality (CMC)

      required · 20 d

      Chemistry, Manufacturing, Controls

   4. ### Module 4 - Non-clinical Reports
      required · 20 d

   5. ### Module 5 - Clinical Reports
      required · 20 d

10. Phase 10

    ## Marketing Authorisation Application (AMM)

    Marketing Authorization Application (MAA) via EMA or national procedure

    1. ### Submission du dossier AMM

       required · 10 d

       Submission du dossier CTD complet

    2. ### Authority Evaluation

       required · 300 d

       EMA/ANSM assessment (210 days with clock stop)

    3. ### Responses to questions

       required · 40 d

       Respond to authority questions (list of questions)

    4. ### Obtaining the Marketing Authorisation

       required · 15 d

       Marketing authorization granted

11. Phase 11

    ## Pharmacovigilance and post-MA surveillance

    Mandatory pharmacovigilance system

    1. ### Set up the pharmacovigilance system

       required · 15 d

       QPPV (Qualified Person for Pharmacovigilance), procedures

    2. ### Risk Management Plan (RMP)

       required · 10 d

       Risk Management Plan - Document mandatory

    3. ### PSUR (Periodic Safety Update Report)

       required · 5 d

       Periodic safety reports

The detailed guide for each step — how to proceed, best practices, common mistakes — is reserved for Normiq accounts.

## Track these deadlines device by device

Normiq places every deadline in your device's roadmap, with the steps that lead to it. Free 7-day trial.

[Open this roadmap in Normiq](https://normiq.app/signup)

## Other pathways on this market

- [Class A IVD](https://normiq.app/en/roadmap/switzerland/ivd-class-a)
- [Class B IVD](https://normiq.app/en/roadmap/switzerland/ivd-class-b)
- [Class C IVD](https://normiq.app/en/roadmap/switzerland/ivd-class-c)
- [Class D IVD](https://normiq.app/en/roadmap/switzerland/ivd-class-d)
- [Class I medical device](https://normiq.app/en/roadmap/switzerland/class-i)
- [Class IIa medical device](https://normiq.app/en/roadmap/switzerland/class-iia)
- [Class IIb medical device](https://normiq.app/en/roadmap/switzerland/class-iib)
- [Class III medical device](https://normiq.app/en/roadmap/switzerland/class-iii)
